Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Betting On STMicroelectronics N.V. (ADR) (STM)

Page 1 of 2

At the moment, there are tons of gauges shareholders can use to monitor the equity markets. A couple of the most underrated are hedge fund and insider trading activity. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the best fund managers can beat their index-focused peers by a significant amount (see just how much).

Just as key, bullish insider trading activity is another way to look at the world of equities. Obviously, there are a number of reasons for an executive to downsize shares of his or her company, but just one, very obvious reason why they would initiate a purchase. Various empirical studies have demonstrated the impressive potential of this strategy if investors know where to look (learn more here).

Now that that’s out of the way, it’s important to analyze the latest info surrounding STMicroelectronics N.V. (ADR) (NYSE:STM).

How have hedgies been trading STMicroelectronics N.V. (ADR) (NYSE:STM)?

Heading into Q3, a total of 11 of the hedge funds we track were long in this stock, a change of 22% from one quarter earlier. With the smart money’s capital changing hands, there exists a select group of key hedge fund managers who were increasing their holdings substantially.

STMicroelectronics N.V. (ADR) (NYSE:STM)When using filings from the hedgies we track, Youlia Miteva’s Proxima Capital Management had the largest position in STMicroelectronics N.V. (ADR) (NYSE:STM), worth close to $17.9 million, comprising 4.1% of its total 13F portfolio. Sitting at the No. 2 spot is George Soros of Soros Fund Management, with a $15.9 million position; the fund has 0.2% of its 13F portfolio invested in the stock. Remaining peers that hold long positions include William B. Gray’s Orbis Investment Management, Peter Rathjens Bruce Clarke and John Campbell’s Arrowstreet Capital and Jim Simons’s Renaissance Technologies.

As one would understandably expect, certain bigger names were breaking ground themselves. Proxima Capital Management, managed by Youlia Miteva, initiated the largest position in STMicroelectronics N.V. (ADR) (NYSE:STM). Proxima Capital Management had 17.9 million invested in the company at the end of the quarter. George Soros’s Soros Fund Management also made a $15.9 million investment in the stock during the quarter. The following funds were also among the new STM investors: William B. Gray’s Orbis Investment Management, Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital, and Jim Simons’s Renaissance Technologies.

How are insiders trading STMicroelectronics N.V. (ADR) (NYSE:STM)?

Bullish insider trading is best served when the company in focus has seen transactions within the past six months. Over the latest half-year time frame, STMicroelectronics N.V. (ADR) (NYSE:STM) has seen zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll go over the relationship between both of these indicators in other stocks similar to STMicroelectronics N.V. (ADR) (NYSE:STM). These stocks are Freescale Semiconductor Ltd (NYSE:FSL), AU Optronics Corp. (ADR) (NYSE:AUO), Maxim Integrated Products Inc. (NASDAQ:MXIM), Avago Technologies Ltd (NASDAQ:AVGO), and NXP Semiconductors NV (NASDAQ:NXPI). This group of stocks are in the semiconductor – broad line industry and their market caps resemble STM’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!